Gilead Sciences (GILD) Receivables - Net (2009 - 2026)
Gilead Sciences' Receivables - Net came in at $5.06 billion for Q2 2026, up 5.7% from $4.78 billion a year earlier and up 6.6% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences' Receivables - Net was $4.91 billion, up 11.2% from FY2024.
- Receivables - Net carries a five-year compound annual growth rate of 0.1% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $4.42 billion in FY2024 (-5.2%), $4.66 billion in FY2023 (-2.4%), $4.78 billion in FY2022 (+6.3%) and $4.49 billion in FY2021 (-8.2%).
- The five-year range for quarterly Receivables - Net is $3.79 billion (Q1 2022) to $5.1 billion (Q3 2025).
- Year-over-year, Receivables - Net has increased for five consecutive quarters, with growth averaging 2.9% over the last eight quarters.
- The fastest year-over-year change in Receivables - Net over five years came in Q3 2021 (growth of 16.7%), and the weakest in Q4 2021 (a decline of 8.2%).
- Business Quant data shows GILD's Receivables - Net at $4.74 billion (Q1 2026), $4.91 billion (Q4 2025) and $5.1 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.06 Bn |
| Mar 31, 2026 | 4.74 Bn |
| Dec 31, 2025 | 4.91 Bn |
| Sep 30, 2025 | 5.10 Bn |
| Jun 30, 2025 | 4.78 Bn |
| Mar 31, 2025 | 4.39 Bn |
| Dec 31, 2024 | 4.42 Bn |
| Sep 30, 2024 | 4.59 Bn |
| Jun 30, 2024 | 4.66 Bn |
| Mar 31, 2024 | 4.67 Bn |
| Dec 31, 2023 | 4.66 Bn |
| Sep 30, 2023 | 4.79 Bn |
| Jun 30, 2023 | 4.23 Bn |
| Mar 31, 2023 | 4.16 Bn |
| Dec 31, 2022 | 4.78 Bn |
| Sep 30, 2022 | 4.35 Bn |
| Jun 30, 2022 | 4.12 Bn |
| Mar 31, 2022 | 3.79 Bn |
| Dec 31, 2021 | 4.49 Bn |
| Sep 30, 2021 | 4.57 Bn |
API Access
Gilead Sciences Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();